Public health guidance on active case finding of communicable diseases in prison settings
This joint guidance from ECDC and the European Monitoring Centre for Drugs and Drug Addiction provides EU/EEA Member States with evidence-based scientific advice on active case finding options. These options can be applied to the planning and implementation of interventions that promote the early diagnosis of communicable diseases in prison settings.
ECDC and EMCDDA make the case for active case finding of communicable diseases in prison
In their joint public health Guidance published today, ECDC and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), present the evidence on active case finding as a key measure to diagnose communicable diseases early.
Public health guidance on prevention and control of blood-borne viruses in prison settings
This document provides EU/EEA Member States with evidence-based scientific advice on available options, when planning and implementing prevention and control interventions for blood-borne viruses in prison settings.
Preventing blood-borne viruses in prison settings: ECDC and EMCDDA Guidance
People in prison experience a higher burden of communicable diseases such as hepatitis B (HBV), hepatitis C (HCV) and HIV often linked to a history of injecting drug use.
Guidance in brief: Prevention and control of blood-borne viruses in prison settings
This guidance is intended for policymakers responsible for the planning and delivery of healthcare services in the national or sub-national custodial system and all professionals responsible for the health and well-being of people in prison, including community-based service providers and those facilitating continuity of care in the community.
Systematic review on the prevention and control of blood-borne viruses in prison settings
The objective of this report was to systematically review data on prevention and control of BBVs in prison settings, with a focus on the countries of the European Union (EU) and the European Economic Area (EEA).
PRECEPT: An evidence assessment framework for infectious disease epidemiology, prevention and control
Harder, T., Takla, A., Eckmanns, T., Ellis, S., Forland, F., James, R., Meerpohl, J.J., Morgan, A., Rehfuess, E., Schünemann, H., Zuiderent-Jerak, T., De Carvalho Gomes, H., Wichmann, O.
Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: A protocol for a suite of systematic reviews for public health and health systems
Pottie, K., Mayhew, A.D., Morton, R.L., Greenaway, C., Akl, E.A., Rahman, P., Zenner, D., Pareek, M., Tugwell, P., Welch, V., Meerpohl, J., Alonso-Coello, P., Hui, C., Biggs, B.-A., Requena-Méndez, A., Agbata, E., Noori, T., Schünemann, H.J.
Hepatitis b and c prevalence and incidence in key population groups with multiple risk factors in the EU/ EEA: A systematic review
Mason, L.M.K., Duffell, E., Veldhuijzen, I.K., Petriti, U., Bunge, E.M., Tavoschi, L.
Strengthening screening for infectious diseases and vaccination among migrants in Europe: What is needed to close the implementation gaps?
Noori, T., Hargreaves, S., Greenaway, C., van der Werf, M., Driedger, M., Morton, R.L., Hui, C., Requena-Mendez, A., Agbata, E., Myran, D.T., Pareek, M., Campos-Matos, I., Nielsen, R.T., Semenza, J., Nellums, L.B., Pottie, K.